LNTH — Lantheus Holdings Share Price
0.000.00%
Last trade - 00:00- $6.94bn
- $6.59bn
- $1.53bn
- 92
- 40
- 88
- 86
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 13.88 | ||
| PEG Ratio (f) | 0.46 | ||
| EPS Growth (f) | 43.15% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.38 | ||
| Price to Tang. Book | 8.02 | ||
| Price to Free Cashflow | 14.92 | ||
| Price to Sales | 4.52 | ||
| EV to EBITDA | 12.62 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 26.27% | ||
| Return on Equity | 32.82% | ||
| Operating Margin | 29.79% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 339.41 | 425.21 | 935.06 | 1,296.43 | 1,533.91 | 1,590.76 | 1,786.69 | 34.59% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -95.04 | n/a | n/a | +1324.35 | -25.43 | +64.54 | +12.62 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. It classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, others. Its OCTEVY is a registrational-stage positron emission tomography (PET) diagnostic imaging agent targeting neuroendocrine tumors.
Directors
- Brian Markison NEC (56)
- Mary Heino PRE (61)
- Robert Marshall CFO (54)
- Vivian Yao CHO
- Daniel Niedzwiecki SVP
- Etienne Montagut SVP (46)
- Carol Walker SVP (58)
- Linda Lennox VPR (56)
- Paul Blanchfield OTH (40)
- Gerard Ber IND (63)
- Samuel Leno IND (75)
- Heinz Maeusli IND (58)
- Julie Mchugh IND (56)
- Gary Pruden IND (60)
- James Thrall IND (77)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 30th, 2007
- Public Since
- June 25th, 2015
- No. of Shareholders
- 29
- No. of Employees
- 808
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Market
- Shares in Issue
- 68,480,308
- Address
- 331 Treble Cove Rd, NORTH BILLERICA, 01862
- Web
- https://www.lantheus.com/
- Phone
- +1 9786718001
- Contact
- Mark Kinarney
- Auditors
- Deloitte & Touche LLP
Upcoming Events for LNTH
Lantheus Holdings Inc Annual Shareholders Meeting
Q1 2025 Lantheus Holdings Inc Earnings Release
Q2 2025 Lantheus Holdings Inc Earnings Release
Similar to LNTH
908 Devices
NASDAQ Global Market
Alpha Teknova
NASDAQ Global Market
Anteris Technologies Global
NASDAQ Global Market
AtriCure
NASDAQ Global Market
Beta Bionics
NASDAQ Global Market
FAQ
What is the Lantheus Holdings share price?
As of Today at 21:42 UTC, shares in Lantheus Holdings are trading at $101.32. This share price information is delayed by 15 minutes.
How has the Lantheus Holdings share price performed this year?
Shares in Lantheus Holdings last closed at $101.32 and the price had moved by +64.8% over the past 365 days. In terms of relative price strength the Lantheus Holdings share price has outperformed the S&P500 Index by +54.96% over the past year.
What are the analyst and broker recommendations for Lantheus Holdings?
The overall consensus recommendation for Lantheus Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Lantheus Holdings dividend yield?
Lantheus Holdings does not currently pay a dividend.
Does Lantheus Holdings pay a dividend?
Lantheus Holdings does not currently pay a dividend.
When does Lantheus Holdings next pay dividends?
Lantheus Holdings does not currently pay a dividend.
How do I buy Lantheus Holdings shares?
To buy shares in Lantheus Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Lantheus Holdings?
As of the previous close price of $101.32, shares in Lantheus Holdings had a market capitalisation of $6.94bn.
Where are Lantheus Holdings shares listed?
Here are the trading details for Lantheus Holdings:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: LNTH
What kind of share is Lantheus Holdings?
Based on an overall assessment of its quality, value and momentum Lantheus Holdings is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Lantheus Holdings share price forecast for 2025?
The analyst consensus target price for shares in Lantheus Holdings is $134.38. That is 32.63% above the last closing price of $101.32.
Analysts covering Lantheus Holdings currently have a consensus Earnings Per Share (EPS) forecast of $7.04 for the next financial year.
Find out moreWhat is the trend in the Lantheus Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lantheus Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -3.78%.
As of the last closing price of $101.32, shares in Lantheus Holdings were trading +2.9% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Lantheus Holdings PE Ratio?
The Lantheus Holdings PE ratio based on its reported earnings over the past 12 months is 13.88. The shares last closed at $101.32.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Lantheus Holdings?
Lantheus Holdings' management team is headed by:
- Brian Markison - NEC
- Mary Heino - PRE
- Robert Marshall - CFO
- Vivian Yao - CHO
- Daniel Niedzwiecki - SVP
- Etienne Montagut - SVP
- Carol Walker - SVP
- Linda Lennox - VPR
- Paul Blanchfield - OTH
- Gerard Ber - IND
- Samuel Leno - IND
- Heinz Maeusli - IND
- Julie Mchugh - IND
- Gary Pruden - IND
- James Thrall - IND